Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07108426Not ApplicableCompleted

Medical Education to Improve Diabetes Care and Outcomes in Hospitalized Patients

Role: lead

NCT05272800Not ApplicableCompleted

BIS-guided Fluid Management in HD Patients

Role: lead

NCT05273424Enrolling By Invitation

Clinical Outcomes of Hemodialysis in Brazil (COHEBRA): a Prospective Cohort Study

Role: lead

NCT02936440Completed

Assessment of Hydration Status Using Bioelectrical Impedance Vector Analysis

Role: lead

NCT02563041Phase 4Completed

Comparative Effectiveness of 30%TSC and Heparin Lock Solution in Hemodialysis Catheters

Role: lead

NCT02282592Completed

Metabolic Syndrome and Female Breast Cancer

Role: lead

All 6 trials loaded